| Patent application number | Description | Published |
|---|
| 20130095302 | GRAYSCALE RENDERING IN 3D PRINTING - An additive three-dimensional fabrication process uses multiple build materials with different optical properties (e.g., color, opacity) at different surface depths to achieve grayscale-rendered images on exterior surfaces thereof. | 04-18-2013 |
| 20130297320 | VOICE-CONTROLLED THREE-DIMENSIONAL FABRICATION SYSTEM - An additive three-dimensional fabrication system includes voice control for user interaction. This voice-controlled interface can enable a variety of voice-controlled functions and operations, while supporting interactions specific to consumer-oriented fabrication processes. | 11-07-2013 |
| 20130329243 | DOWNLOADABLE THREE-DIMENSIONAL MODELS - A server is configured to store a number of different models of an object in machine-ready form corresponding to a number of different three-dimensional printers having differing capabilities and/or hardware configurations. When a user at a client device or a printer requests the object, the server automatically determines a printer type and selects a suitable, corresponding machine-ready model for immediate fabrication by the printer. | 12-12-2013 |
| 20130329257 | DOWNLOADABLE THREE-DIMENSIONAL MODELS - A server is configured to store a number of different models of an object in machine-ready form corresponding to a number of different three-dimensional printers having differing capabilities and/or hardware configurations. When a user at a client device or a printer requests the object, the server automatically determines a printer type and selects a suitable, corresponding machine-ready model for immediate fabrication by the printer. | 12-12-2013 |
| 20130329258 | DOWNLOADABLE THREE-DIMENSIONAL MODELS - A server is configured to store a number of different models of an object in machine-ready form corresponding to a number of different three-dimensional printers having differing capabilities and/or hardware configurations. When a user at a client device or a printer requests the object, the server automatically determines a printer type and selects a suitable, corresponding machine-ready model for immediate fabrication by the printer. | 12-12-2013 |
| 20140036034 | THREE-DIMENSIONAL PRINTER WITH LASER LINE SCANNER - A three-dimensional printer includes a laser line scanner and hardware to rotate the scanner relative to an object on a build platform. In this configuration, three-dimensional surface data can be obtained from the object, e.g., for use as an input to subsequent processing steps such as the generation of tool instructions to fabricate a three-dimensional copy of the object, or various surfaces thereof. | 02-06-2014 |
| 20140036035 | PRINTER WITH LASER SCANNER AND TOOL-MOUNTED CAMERA - A three-dimensional printer includes a laser line scanner and hardware to rotate the scanner relative to an object on a build platform. In this configuration, three-dimensional surface data can be obtained from the object, e.g., for use as an input to subsequent processing steps such as the generation of tool instructions to fabricate a three-dimensional copy of the object, or various surfaces thereof. | 02-06-2014 |
| 20140043441 | MOBILE DEVICE ACCESSORY FOR THREE-DIMENSIONAL SCANNING - A variety of techniques are disclosed for enabling three-dimensional scanning with mobile devices. In general, an accessory provides additional optics, image sensors, lighting and/or processing to complement preexisting device hardware in support of a variety of three-dimensional imaging techniques. | 02-13-2014 |
| 20140043442 | MOBILE DEVICE ACCESSORY FOR THREE-DIMENSIONAL SCANNING - A variety of techniques are disclosed for enabling three-dimensional scanning with mobile devices. In general, an accessory provides additional optics, image sensors, lighting and/or processing to complement preexisting device hardware in support of a variety of three-dimensional imaging techniques. | 02-13-2014 |
| 20140265035 | THREE-DIMENSIONAL PRINTING WITH CONTROL OF THERMOALTERABLE BUILD MATERIALS - A variety of thermoalterable build materials are disclosed for use in three-dimensional printing, along with techniques for controlling properties of such materials in a fabricated object. In particular, changes in material flow rate permit instantaneous changes in heat transfer and resulting variations in the amount of thermoalteration, without requiring any changes to the temperature of a heater or extruder used to extrude the material. In this manner, flow rate facilitates spatial control of properties within a fabricated object. | 09-18-2014 |
| Patent application number | Description | Published |
|---|
| 20130041091 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST - The present invention relates to a crosslinkable composition comprising at least one crosslinkable component crosslinkable by a latent base crosslinking catalyst comprising a substituted carbonate salt according to formula 1 wherein X | 02-14-2013 |
| 20130053505 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST - The present invention relates to a crosslinkable composition comprising at least one crosslinkable component and a latent base crosslinking catalyst, which crosslinkable composition has a solids content of typically at least 55 wt (dry weight after crosslinking relative to the total weight of the crosslinking composition) wherein the latent base catalyst is a substituted carbonate salt according to formula (I) wherein X | 02-28-2013 |
| 20130210986 | CROSSLINKABLE COMPOSITION CROSSLINKABLE WITH A LATENT BASE CATALYST - The present invention relates to a crosslinkable composition comprising at least one crosslinkable component and a latent base crosslinking catalyst, which crosslinkable composition has a solids content of typically at least 55 wt (dry weight after crosslinking relative to the total weight of the crosslinking composition) wherein the latent base catalyst is a substituted carbonate salt according to formula (I) wherein X | 08-15-2013 |
| 20140220252 | CROSSLINKABLE COMPOSITION COMPRISING A LATENT BASE CATALYST AND LATENT BASE CATALYST COMPOSITIONS - A crosslinkable composition including at least one crosslinkable component that is crosslinkable under the action of a base catalyst, a first carbonate salt according to a first formula as latent base crosslinking catalyst, and a second carbonate salt according to a second formula as potlife extender, wherein the second carbonate is present in an amount of at least 5 mole % and preferably at most 500 mole % relative to the molar amount of the first carbonate. Further disclosed are catalyst compositions composed of the first and second carbonate salts, to the use of the catalyst composition as base catalyst system in crosslinkable compositions and the crosslinkable compositions, in particular coating compositions comprising the catalyst composition. | 08-07-2014 |
| 20140221542 | CROSSLINKABLE COMPOSITION CROSS-LINKABLE BY REAL MICHAEL ADDITION REACTION AND RESINS FOR USE IN SAID COMPOSITION - An RMA crosslinkable composition having at least one crosslinkable component including reactive components A and B each including at least 2 reactive groups, the at least 2 reactive groups of component A being acidic protons (C—H) in activated methylene or methine groups and the at least 2 reactive groups of component B are activated unsaturated groups (C═C) and a base catalyst (C) which reactive components A and B crosslink by Real Michael Addition (RMA) reaction under action of the base catalyst, characterised in that the at least one crosslinkable component including reactive components A and B in the composition have a total hydroxy number of less than 60, preferably less than 40 and more preferably less than 20 mg KOH/g solids. Further, specific resins A and B having a low hydroxy number for use in RMA cross-linkable compositions and a process for the manufacture thereof. | 08-07-2014 |
| 20140235785 | CROSSLINKABLE COMPOSITION CROSSLINKABLE BY REAL MICHAEL ADDITION (RMA) REACTION - A crosslinkable composition including a component A with at least 2 acidic protons C—H in activated methylene or methine groups (the RMA donor group), and a component B with at least 2 activated unsaturated groups (the RMA acceptor group), and a catalyst system C that contains, or is able to generate a basic catalyst capable of activating the RMA reaction between components A and B, characterised in that the cross-linkable composition further includes an X—H group containing component D that is also a Michael addition donor reactable with component B under the action of catalyst C, wherein X is N, P, O, S or wherein X is C as part of an acidic methyl (CH3) group. A component D and catalyst additive mixtures for the manufacture of RMA crosslinkable composition. | 08-21-2014 |
| 20160060482 | CROSSLINKABLE COMPOSITION - An RMA crosslinkable composition for making thick coating layers having at least one crosslinkable component comprising reactive components A and B each including at least 2 reactive groups wherein the at least 2 reactive groups of component A are acidic protons (C—H) in activated methylene or methine groups, and the at least 2 reactive groups of component B are activated unsaturated groups (C═C), to achieve crosslinking by Real Michael Addition reaction, the composition further including a base catalyst (C), an X—H group containing component (D) that is also a Michael addition donor reactable with component B under the action of catalyst C, wherein X is C, N, P, O or S and a sag control component (E). A crosslinkable composition is also disclosed for preparing thick coating layers having a dry thickness of at least 70 mu having a surface appearance and hardness of the resulting cured composition. | 03-03-2016 |
| Patent application number | Description | Published |
|---|
| 20090063277 | ASSOCIATING INFORMATION WITH A PORTION OF MEDIA CONTENT - A media fingerprint is derived from a portion of media content. Information is associated with the media content portion based on the derived media fingerprint. Upon linking to the associated information, the associated content is presented with the media content portion. The media fingerprint includes a unique representation of the media content portion that is derived from a characteristic component of the media content portion. The media content may comprise an original instance of content or a derivative instance of the original content. | 03-05-2009 |
| 20110022589 | ASSOCIATING INFORMATION WITH MEDIA CONTENT USING OBJECTS RECOGNIZED THEREIN - At least one object within a portion of media content is recognized. The object is essentially a feature of the media content portion. Information is associated with the recognized object based on recognizing the object. | 01-27-2011 |
| 20120099760 | ASSOCIATING INFORMATION WITH A PORTION OF MEDIA CONTENT - A media fingerprint is derived from a portion of media content. Information is associated with the media content portion based on the derived media fingerprint. Upon linking to the associated information, the associated content is presented with the media content portion. The media fingerprint includes a unique representation of the media content portion that is derived from a characteristic component of the media content portion. The media content may comprise an original instance of content or a derivative instance of the original content. | 04-26-2012 |
| 20120143679 | ASSOCIATING INFORMATION WITH A PORTION OF MEDIA CONTENT - A media fingerprint is derived from a portion of media content. Information is associated with the media content portion based on the derived media fingerprint. Upon linking to the associated information, the associated content is presented with the media content portion. The media fingerprint includes a unique representation of the media content portion that is derived from a characteristic component of the media content portion. The media content may comprise an original instance of content or a derivative instance of the original content. | 06-07-2012 |
| Patent application number | Description | Published |
|---|
| 20150203806 | SYSTEMS FOR DISRUPTING BIOLOGICAL SAMPLES AND ASSOCIATED DEVICES AND METHODS - The present technology relates generally to systems for disrupting biological samples and associated devices and methods. In some embodiments, system includes a vessel configured to receive the biological sample, a permanent magnet configured to be positioned within the vessel, an electromagnet configured to be positioned proximate the vessel, and a current source operably coupled to the electromagnet and configured to transmit an alternating current. In some embodiments, when the biological sample is placed within the vessel and the alternating current is transmitted to the electromagnet, the electromagnet produces an alternating magnetic field that causes the permanent magnet to rotate within the vessel, thereby lysing at least one of the cells of the biological sample. | 07-23-2015 |
| 20150361487 | SEQUENTIAL DELIVERY OF FLUID VOLUMES AND ASSOCIATED DEVICES, SYSTEMS AND METHODS - The present technology is directed to capillarity-based devices for performing chemical processes and associated system and methods. In one embodiment, for example, a device can include a porous receiving element having an input region and a receiving region, a first fluid source and a second fluid source positioned within the input region of the receiving element; wherein the first fluid source is positioned between the second fluid source and the receiving region, and wherein, when both the first and second fluid sources are in fluid connection with the input region, the device is configured to sequentially deliver the first fluid and the second fluid to the receiving region without leakage. | 12-17-2015 |
| Patent application number | Description | Published |
|---|
| 20120136081 | Resorbable Polyurethane Wound Cover - The present invention relates to a biocompatible, resorbable polyurethane foam wound cover with open pores and an adjustable resorption rate having improved properties when used on skin or connective tissue wounds as well as a method of production of such a polyurethane foam wound cover. | 05-31-2012 |
| 20130288034 | Resorbable Membrane - The present invention relates to resorbable membranes for medical uses. The membranes according to the present invention are produced or producible from a composition comprising at least one polyol component, at least one polyisocyanate component and an additive selected from polyvinylpyrrolidone, polyvinylpolypyrrolidone, a copolymer of polyvinylpyrrolidone with vinylacetate, vinylimidazole or vinylcaprolactam or mixtures thereof. The present invention further relates to a kit comprising a multitude of membranes with different absorption rates. | 10-31-2013 |
| 20150247074 | Method for Producing a Two-Component Polyurethane Composition Comprising One or More Additives Soluble in Polar Solvents - A method for producing a two-component polyurethane composition comprising at least one additive soluble in polar solvents, in particular a biocide, comprising the following steps: a) providing at least one polyol; b) adding at least one solution of the polar solvent comprising at least one additive soluble in polar solvents, in particular a biocide, and at least one carrier material for the additive to the polyol from step a); and c) providing, in accordance with the requirements, at least one isocyanate for adding to the mixture from step b). The method has the advantage that additives can be incorporated into a two-component polyurethane composition without agglomerating or precipitating, without side reactions, and without an additional drying step. | 09-03-2015 |
| Patent application number | Description | Published |
|---|
| 20110097394 | TYPE A GELATIN CAPSULE CONTAINING PUFA IN FREE ACID FORM - A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule characterised in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft gelatin capsule containing the same formulation but comprising gelatin extracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life. | 04-28-2011 |
| 20130123362 | TYPE A GELATIN CAPSULE CONTAINING PUFA IN FREE ACID FORM - A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule characterised in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft to gelatin capsule containing the same formulation but comprising gelatin extracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life. | 05-16-2013 |
| 20140056980 | DELAYED RELEASE DRUG FORMULATION - In a delayed release formulation comprising a core containing a drug and a delayed release coating for providing intestinal release, release of the drug in the colon is accelerated by including an isolation layer between the core and the delayed release coating. The delayed release coating comprises an inner layer and an outer layer. The outer layer comprises a pH dependently soluble polymeric material which has a pH threshold at about pH 5 or above. The inner layer comprises a soluble polymeric material which is soluble in intestinal fluid or gastrointestinal fluid, said soluble polymeric material being selected from the group consisting of a polycarboxylic acid polymer that is at least partially neutralised, and a non-ionic polymer, provided that, where said soluble polymeric material is a non-ionic polymer, said inner layer comprises at least one additive selected from a buffer agent and a base. | 02-27-2014 |
| 20150125525 | DELAYED RELEASE DRUG FORMULATION - Delayed release of a drug to the colon is achieved from a delayed release formulation comprising a core and a coating for the core. The core comprises a drug and the coating comprises an inner layer and an outer layer. The outer layer comprises a mixture of a first polymeric material which is susceptible to attack by colonic bacteria, and a second polymeric material which has a pH threshold at about pH 5 or above. The inner layer comprises a third polymeric material which is soluble in intestinal fluid or gastrointestinal fluid, said third polymeric material being selected from an at least partially neutralised polycarboxylic acid and a non-ionic polymer. In embodiments in which the third polymeric material is a non-ionic polymer, the inner layer comprises at least one of a buffer agent and a base. Advantages of formulations according to the present invention include accelerated release of the drug when exposed to colonic conditions and reduction or elimination of a food and/or alcohol effect on drug release after administration. | 05-07-2015 |
| 20150132380 | A DELAYED RELEASE DRUG FORMULATION - Delayed release of a drug to the colon is achieved from a delayed release formulation comprising a core and a coating for the core. The core comprises a drug and the coating comprises an outer layer and at least one layer between the core and the outer layer selected from the group consisting of an isolation layer and an inner layer. The outer layer comprises a mixture of a first polymeric material which is susceptible to attack by colonic bacteria, and a second polymeric material which has a pH threshold at about pH 5 or above. The inner layer comprises a third polymeric material which is soluble in intestinal fluid or gastrointestinal fluid, said third polymeric material being selected from an at least partially neutralised polycarboxylic acid and a non-ionic polymer. In embodiments in which the third polymeric material is a non-ionic polymer, the inner layer comprises at least one of a buffer agent and a base. The isolation layer comprises a non-ionic polymer which is soluble in intestinal fluid or gastrointestinal fluid. The outer is applied directly to the inner layer or the isolation layer using a coating preparation formed by combining the first polymeric material in an aqueous medium with a second polymeric material in an organic medium. Advantages of formulations according to the present invention include accelerated release of the drug when exposed to colonic conditions and reduction or elimination of a food and/or alcohol effect on drug release after administration. | 05-14-2015 |
| 20150238430 | PHARMACEUTICAL COMPOSITION - A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule characterised in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft gelatin capsule containing the same formulation but comprising gelatin extracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life. | 08-27-2015 |
